DCGO DocGo Inc.

Nasdaq docgo.com


$ 1.08 $ 0.06 (5.88 %)    

Wednesday, 05-Nov-2025 16:56:26 EST
QQQ $ 622.38 $ 4.94 (0.8 %)
DIA $ 473.04 $ 2.23 (0.47 %)
SPY $ 677.28 $ 2.47 (0.37 %)
TLT $ 89.01 $ -0.57 (-0.64 %)
GLD $ 365.20 $ 0.10 (0.03 %)
$ 1.08
$ 1.03
$ 1.08 x 188
$ 1.13 x 200
$ 1.02 - $ 1.09
$ 1.01 - $ 5.68
617,127
na
105.63M
$ 1.04
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-07-2025 06-30-2025 10-Q
2 05-08-2025 03-31-2025 10-Q
3 02-27-2025 12-31-2024 10-K
4 11-07-2024 09-30-2024 10-Q
5 08-07-2024 06-30-2024 10-Q
6 05-08-2024 03-31-2024 10-Q
7 02-28-2024 12-31-2023 10-K
8 11-06-2023 09-30-2023 10-Q
9 08-08-2023 06-30-2023 10-Q
10 05-09-2023 03-31-2023 10-Q
11 03-14-2023 12-31-2022 10-K
12 11-08-2022 09-30-2022 10-Q
13 08-09-2022 06-30-2022 10-Q
14 05-10-2022 03-31-2022 10-Q
15 03-15-2022 12-31-2021 10-K
16 11-15-2021 09-30-2021 10-Q
17 08-11-2021 06-30-2021 10-Q
18 06-03-2021 03-31-2021 10-Q
19 03-30-2021 12-31-2020 10-K
20 11-25-2020 09-30-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 docgo-plans-to-roll-out-longitudinal-care-services-in-q4-in-collaboration-with-california-based-insurance-provider

DocGo Inc. (Nasdaq: DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health an...

 docgo-acquires-virtual-care-platform-steadymd-no-financial-terms-disclosed-in-2025-steadymd-is-expected-to-generate-25m-in-revenue-and-is-expected-to-be-ebitda-positive-for-2026

Strategic Acquisition Combines DocGo's Last Mile Healthcare Delivery Capabilities With SteadyMD's Virtual Care Platform...

 canaccord-genuity-maintains-hold-on-docgo-raises-price-target-to-16

Canaccord Genuity analyst Richard Close maintains DocGo (NASDAQ:DCGO) with a Hold and raises the price target from $1.45 to ...

 docgo-affirms-fy2025-sales-guidance-of-300000m-330000m-vs-314472m-est

DocGo (NASDAQ:DCGO) affirms FY2025 sales outlook from $300.000 million-$330.000 million to $300.000 million-$330.000 million vs...

 docgo-q2-eps-011-misses-009-estimate-sales-80418m-beat-77569m-estimate

DocGo (NASDAQ:DCGO) reported quarterly losses of $(0.11) per share which missed the analyst consensus estimate of $(0.09) by 17...

 docgo-extends-share-repurchase-program-to-december-31-2025

-SEC Filing

 canaccord-genuity-downgrades-docgo-to-hold-lowers-price-target-to-145

Canaccord Genuity analyst Richard Close downgrades DocGo (NASDAQ:DCGO) from Buy to Hold and lowers the price target from $5 ...

 needham-maintains-buy-on-docgo-lowers-price-target-to-3

Needham analyst Ryan MacDonald maintains DocGo (NASDAQ:DCGO) with a Buy and lowers the price target from $4 to $3.

 docgo-lowers-fy2025-sales-guidance-from-41000m-45000m-to-30000m-33000m

DocGo (NASDAQ:DCGO) lowers FY2025 sales outlook from $410.00 million-$450.00 million to $300.00 million-$330.00 million.

 docgo-q1-eps-009-misses-002-estimate-sales-9603m-miss-10425m-estimate

DocGo (NASDAQ:DCGO) reported quarterly losses of $(0.09) per share which missed the analyst consensus estimate of $(0.02) by 35...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION